$ Value
$0
Shares
31,250
Price
$0
Filed
Nov 14
Insider
Name
Randhawa Simrat
Title
EVP, Head of R&D
CIK
0001992260
Roles
Transaction Details
Transaction Date
2025-11-14
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
118,750
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.48 to $36.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.48 to $37.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.48 to $38.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The shares of common stock underlying this stock option award vested as to 25% of the shares on April 25, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date. | The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. | The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. | The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
Filing Info
Randhawa Simrat's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-12 | DNTH | M | $68K |
| 2026-03-12 | DNTH | M | $89K |
| 2026-03-12 | DNTH | M | $181K |
| 2026-03-12 | DNTH | M | $276K |
| 2026-03-12 | DNTH | ▼ | $2.8M |
| 2026-03-12 | DNTH | M | $0 |
| 2026-03-12 | DNTH | M | $0 |
| 2026-03-12 | DNTH | M | $0 |
| 2026-03-12 | DNTH | M | $0 |
| 2026-02-03 | DNTH | A | $0 |
Other Insiders at DNTH (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
CARR EDWARD
CHIEF ACCOUNTING OFFICER
|
— | $3.6M | 2026-03-12 |
|
Garcia Marino
CEO AND PRESIDENT
|
— | $10.0M | 2026-03-12 |
| Soteropoulos Paula | — | $2.2M | 2026-03-31 |
|
Veness Adam M
SVP, General Counsel and Sec.
|
— | — | 2026-02-03 |
|
Randhawa Simrat
EVP, Head of R&D
|
— | $2.8M | 2026-03-12 |
|
Savitz Ryan
EVP, CFO & CBO
|
— | $10.2M | 2026-04-09 |